Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Neurocrine Biosciences Inc NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:NBIX)

No current opinion is available.

Bullboard Posts (NDAQ:NBIX)

And Soros Buys In?

http://www.gurufocus.com/StockBuy.php?symbol=NBIX
scissors14 - June 29, 2006

Pfizer Rejects Indiplon

U.S. Equity News: AstraZeneca Cholesterol Drug Effective and Abbott Phase III Data Jun 26, 2006 (M2 PRESSWIRE via COMTEX News Network...
scissors14 - June 29, 2006

Clinical trails show

San Diego-based Neurocrine Biosciences (NASDAQ: NBIX) says clinical trials show its new drug can reduce the size of inoperable advanced...
SCCNewsServices - April 19, 2000